Pivot Bio valuation, funding and investors
Pivot Bio works in microbial nitrogen product manufacturing, based in Berkeley, United States. Founded in 2011, it has about 306 employees.
Chemicals Series D
VALUATION · TODAY
$716M −12% after Series D
Range $151M – $3.29B · Grade DTODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
$5.00B
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $0.75M
Series A $16.0M
Series B $70.0M
Series C $100M
Series D $430M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY306 employees
+2%6m growth
−2%1y growth
−29%2y growth
200
400
600
Data from Jan 2021
Predicted in 1 yr $633M −12% vs today
Predicted next raise $345M if a round comes
Winding-down probability 59%
- Last round
- Series D · $430M · Jul 2021
- Valuation at last round
- $2.00B
- Headcount
- 306 · flat
- Grade
- D
- Founded
- 2011
Pivot Bio valuation today
VCMC values Pivot Bio at $716M today, with a range of $151M to $3.3B and a grade of D. The valuation starts from its last funding round, a Series D round in Jul 2021.
Valuation by date (195 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2011 | $4.97M | $1.81M – $13.7M | $4.97M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2011 | $4.97M | $1.81M – $13.7M | $4.99M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2011 | $4.97M | $1.81M – $13.7M | $5.01M (+1%) | before first round | – | unknown | D | 0% |
| 1 Oct 2011 | $4.97M | $1.81M – $13.7M | $5.03M (+1%) | before first round | – | unknown | D | 0% |
| 1 Nov 2011 | $4.97M | $1.81M – $13.7M | $5.05M (+2%) | before first round | – | unknown | D | 0% |
| 1 Dec 2011 | $4.97M | $1.81M – $13.7M | $5.07M (+2%) | before first round | – | unknown | D | 0% |
| 1 Jan 2012 | $4.97M | $1.81M – $13.7M | $5.09M (+2%) | before first round | – | unknown | D | 0% |
| 1 Feb 2012 | $4.97M | $1.81M – $13.7M | $5.11M (+3%) | before first round | – | unknown | D | 0% |
| 1 Mar 2012 | $4.97M | $1.81M – $13.7M | $5.13M (+3%) | before first round | – | unknown | D | 0% |
| 1 Apr 2012 | $4.97M | $1.81M – $13.7M | $5.15M (+4%) | before first round | – | unknown | D | 0% |
| 1 May 2012 | $4.97M | $1.81M – $13.7M | $5.17M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jun 2012 | $4.97M | $1.81M – $13.7M | $5.19M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jul 2012 | $4.97M | $1.81M – $13.7M | $5.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2012 | $4.99M | $1.82M – $13.7M | $5.23M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2012 | $5.01M | $1.83M – $13.8M | $5.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2012 | $5.03M | $1.83M – $13.8M | $5.27M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2012 | $5.05M | $1.84M – $13.9M | $5.30M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2012 | $5.07M | $1.85M – $13.9M | $5.32M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2013 | $5.09M | $1.85M – $14.0M | $5.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $5.11M | $1.86M – $14.0M | $5.36M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $5.13M | $1.87M – $14.1M | $5.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $5.15M | $1.88M – $14.2M | $5.40M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $5.17M | $1.88M – $14.2M | $5.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $5.19M | $1.89M – $14.3M | $5.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $5.21M | $1.90M – $14.3M | $5.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $5.23M | $1.91M – $14.4M | $5.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $5.25M | $1.91M – $14.4M | $5.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $5.27M | $1.92M – $14.5M | $5.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $5.30M | $1.93M – $14.5M | $5.55M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $5.32M | $1.94M – $14.6M | $5.57M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $3.00M | $1.97M – $9.13M | $6.00M (+100%) | after a round | – | unknown | C | 0% |
| 2 Jan 2014 | $3.01M | $1.97M – $9.13M | $6.00M (+100%) | after a round | – | unknown | C | 0% |
| 1 Feb 2014 | $3.18M | $1.97M – $9.13M | $6.00M (+89%) | after a round | – | unknown | C | 0% |
| 1 Mar 2014 | $3.36M | $1.97M – $9.13M | $6.00M (+79%) | after a round | – | unknown | C | 0% |
| 1 Apr 2014 | $3.56M | $1.97M – $9.13M | $6.00M (+69%) | after a round | – | unknown | C | 0% |
| 1 May 2014 | $3.77M | $1.97M – $9.13M | $6.00M (+59%) | after a round | – | unknown | C | 0% |
| 1 Jun 2014 | $4.00M | $1.97M – $9.13M | $6.00M (+50%) | after a round | – | unknown | C | 0% |
| 1 Jul 2014 | $4.23M | $1.97M – $9.13M | $6.00M (+42%) | after a round | – | unknown | C | 0% |
| 1 Aug 2014 | $4.49M | $1.97M – $9.13M | $6.00M (+34%) | after a round | – | unknown | C | 0% |
| 1 Sep 2014 | $4.76M | $1.97M – $9.13M | $6.00M (+26%) | after a round | – | unknown | C | 0% |
| 1 Oct 2014 | $5.04M | $1.97M – $9.13M | $6.00M (+19%) | after a round | – | unknown | C | 0% |
| 1 Nov 2014 | $5.34M | $1.97M – $9.13M | $6.00M (+12%) | after a round | – | unknown | C | 0% |
| 1 Dec 2014 | $5.65M | $1.97M – $9.13M | $6.00M (+6%) | after a round | – | unknown | C | 0% |
| 1 Jan 2015 | $6.00M | $1.97M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2015 | $6.00M | $1.87M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2015 | $6.00M | $1.79M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2015 | $6.00M | $1.70M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2015 | $6.00M | $1.62M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2015 | $6.00M | $1.54M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2015 | $6.00M | $1.46M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2015 | $6.00M | $1.39M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2015 | $6.00M | $1.32M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2015 | $6.00M | $1.26M – $9.13M | $6.00M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2015 | $6.00M | $1.20M – $9.13M | $6.00M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2015 | $6.00M | $1.14M – $9.13M | $6.00M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2016 | $56.7M | $39.9M – $145M | $102M (+80%) | after a round | – | unknown | C | 0% |
| 2 Jan 2016 | $56.8M | $39.9M – $145M | $102M (+80%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $59.6M | $39.9M – $145M | $102M (+71%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $62.4M | $39.9M – $145M | $102M (+63%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $65.6M | $39.9M – $145M | $102M (+55%) | after a round | – | unknown | C | 0% |
| 1 May 2016 | $68.9M | $39.9M – $145M | $102M (+48%) | after a round | – | unknown | C | 0% |
| 1 Jun 2016 | $72.4M | $39.9M – $145M | $102M (+41%) | after a round | – | unknown | C | 0% |
| 1 Jul 2016 | $76.0M | $39.9M – $145M | $102M (+34%) | after a round | – | unknown | C | 0% |
| 1 Aug 2016 | $79.9M | $39.9M – $145M | $102M (+28%) | after a round | – | unknown | C | 0% |
| 1 Sep 2016 | $83.9M | $39.9M – $145M | $102M (+22%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $88.1M | $39.9M – $145M | $102M (+16%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $92.6M | $39.9M – $145M | $102M (+10%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $97.2M | $39.9M – $145M | $102M (+5%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $102M | $39.9M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $102M | $37.9M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $102M | $36.2M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $102M | $34.4M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $102M | $32.8M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $102M | $31.1M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $102M | $29.6M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $102M | $28.2M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $102M | $26.8M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $102M | $25.5M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $102M | $24.2M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $102M | $23.0M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $102M | $21.9M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $102M | $20.8M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $102M | $19.9M – $145M | $102M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $102M | $18.9M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2018 | $102M | $18.0M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2018 | $102M | $17.1M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2018 | $102M | $16.3M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2018 | $102M | $15.5M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2018 | $102M | $14.7M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2018 | $102M | $14.0M – $145M | $102M (0%) | after a round | – | unknown | D | 0% |
| 3 Oct 2018 | $469M | $330M – $997M | $702M (+50%) | after a round | – | unknown | B | 0% |
| 1 Nov 2018 | $484M | $330M – $997M | $702M (+45%) | after a round | – | unknown | B | 0% |
| 1 Dec 2018 | $500M | $330M – $997M | $702M (+40%) | after a round | – | unknown | B | 0% |
| 1 Jan 2019 | $518M | $330M – $997M | $702M (+36%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $536M | $330M – $997M | $702M (+31%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $553M | $330M – $997M | $702M (+27%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $572M | $330M – $997M | $702M (+23%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $592M | $330M – $997M | $702M (+19%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $612M | $330M – $997M | $702M (+15%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $633M | $330M – $997M | $702M (+11%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $655M | $330M – $997M | $702M (+7%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $678M | $330M – $997M | $702M (+4%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $701M | $330M – $997M | $702M (0%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $702M | $316M – $997M | $702M (0%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $702M | $303M – $997M | $702M (0%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $702M | $290M – $997M | $702M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $702M | $277M – $997M | $702M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $702M | $266M – $997M | $702M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $702M | $255M – $997M | $702M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $856M | $603M – $1.6B | $1.1B (+30%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $875M | $603M – $1.6B | $1.1B (+27%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $894M | $603M – $1.6B | $1.1B (+24%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $914M | $603M – $1.6B | $1.1B (+22%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $935M | $603M – $1.6B | $1.1B (+19%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $955M | $603M – $1.6B | $1.1B (+16%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $977M | $603M – $1.6B | $1.1B (+14%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $998M | $603M – $1.6B | $1.1B (+11%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $1.0B | $603M – $1.6B | $1.1B (+9%) | after a round | 130 | unknown | B | 0% |
| 1 Feb 2021 | $1.0B | $603M – $1.6B | $1.1B (+7%) | after a round | 130 | unknown | B | 0% |
| 1 Mar 2021 | $1.1B | $603M – $1.6B | $1.1B (+4%) | after a round | 130 | unknown | B | 0% |
| 1 Apr 2021 | $1.1B | $603M – $1.6B | $1.1B (+2%) | after a round | 130 | flat | B | 0% |
| 1 May 2021 | $1.1B | $602M – $1.6B | $1.1B (0%) | after a round | 130 | flat | B | 0% |
| 1 Jun 2021 | $1.1B | $575M – $1.6B | $1.1B (0%) | after a round | 130 | flat | B | 0% |
| 1 Jul 2021 | $1.1B | $549M – $1.6B | $1.1B (0%) | after a round | 130 | flat | B | 0% |
| 20 Jul 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+30%) | after a round | 130 | flat | A | 0% |
| 1 Aug 2021 | $2.0B | $1.7B – $3.0B | $2.6B (+29%) | after a round | 130 | flat | A | 0% |
| 1 Sep 2021 | $2.1B | $1.7B – $3.0B | $2.6B (+26%) | after a round | 130 | flat | A | 0% |
| 1 Oct 2021 | $2.1B | $1.7B – $3.0B | $2.6B (+23%) | after a round | 130 | flat | A | 0% |
| 1 Nov 2021 | $2.2B | $1.7B – $3.0B | $2.6B (+21%) | after a round | 130 | flat | A | 0% |
| 1 Dec 2021 | $2.2B | $1.7B – $3.0B | $2.6B (+18%) | after a round | 130 | flat | A | 0% |
| 1 Jan 2022 | $2.3B | $1.7B – $3.0B | $2.6B (+15%) | after a round | 130 | flat | A | 0% |
| 1 Feb 2022 | $2.3B | $1.7B – $3.0B | $2.6B (+13%) | after a round | 130 | flat | A | 0% |
| 1 Mar 2022 | $2.4B | $1.7B – $3.0B | $2.6B (+11%) | after a round | 130 | flat | A | 0% |
| 1 Apr 2022 | $2.7B | $1.7B – $3.6B | $3.1B (+14%) | after a round | 300 | growing | B | 0% |
| 1 May 2022 | $2.8B | $1.7B – $3.6B | $3.1B (+10%) | after a round | 300 | growing | B | 0% |
| 1 Jun 2022 | $2.9B | $1.7B – $3.6B | $3.1B (+6%) | after a round | 300 | growing | B | 0% |
| 1 Jul 2022 | $3.1B | $1.7B – $3.6B | $3.1B (+2%) | after a round | 300 | growing | B | 0% |
| 1 Aug 2022 | $3.1B | $1.8B – $3.6B | $3.1B (0%) | after a round | 300 | growing | B | 0% |
| 1 Sep 2022 | $3.1B | $1.8B – $3.6B | $3.1B (0%) | after a round | 300 | growing | B | 0% |
| 1 Oct 2022 | $3.1B | $1.8B – $3.6B | $3.1B (0%) | after a round | 300 | growing | B | 0% |
| 1 Nov 2022 | $3.1B | $1.6B – $3.6B | $3.1B (0%) | after a round | 300 | unknown | B | 0% |
| 1 Dec 2022 | $3.1B | $1.5B – $3.6B | $3.1B (0%) | after a round | 300 | unknown | B | 0% |
| 1 Jan 2023 | $3.1B | $1.5B – $3.6B | $3.1B (0%) | after a round | 300 | unknown | B | 0% |
| 1 Feb 2023 | $3.1B | $1.4B – $3.6B | $3.1B (0%) | after a round | 300 | unknown | B | 0% |
| 1 Mar 2023 | $3.1B | $1.4B – $3.6B | $3.1B (0%) | after a round | 300 | unknown | B | 0% |
| 1 Apr 2023 | $3.4B | $2.2B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 May 2023 | $3.4B | $2.2B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 Jun 2023 | $3.4B | $2.3B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 Jul 2023 | $3.4B | $2.4B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 Aug 2023 | $3.4B | $2.3B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 Sep 2023 | $3.4B | $2.3B – $3.9B | $3.4B (0%) | after a round | 420 | growing | A | 0% |
| 1 Oct 2023 | $3.5B | $2.4B – $4.0B | $3.5B (0%) | after a round | 480 | growing | A | 0% |
| 1 Nov 2023 | $3.5B | $1.7B – $4.0B | $3.4B (-2%) | after a round | 480 | up | B | 0% |
| 1 Dec 2023 | $3.5B | $1.7B – $4.0B | $3.4B (-2%) | after a round | 480 | up | B | 0% |
| 1 Jan 2024 | $3.5B | $1.7B – $4.0B | $3.4B (-2%) | after a round | 480 | up | B | 0% |
| 1 Feb 2024 | $3.5B | $1.6B – $4.0B | $3.4B (-3%) | after a round | 480 | up | B | 0% |
| 1 Mar 2024 | $3.4B | $857M – $3.9B | $3.2B (-5%) | after a round | 430 | flat | C | 0% |
| 1 Apr 2024 | $3.4B | $815M – $3.9B | $3.2B (-6%) | after a round | 430 | flat | C | 0% |
| 1 May 2024 | $3.4B | $775M – $3.9B | $3.2B (-7%) | after a round | 430 | flat | C | 0% |
| 1 Jun 2024 | $3.4B | $737M – $3.9B | $3.1B (-7%) | after a round | 430 | flat | C | 0% |
| 1 Jul 2024 | $3.4B | $702M – $3.9B | $3.1B (-8%) | after a round | 430 | flat | C | 0% |
| 1 Aug 2024 | $3.3B | $667M – $3.9B | $2.9B (-11%) | after a round | 430 | flat | C | 3% |
| 1 Sep 2024 | $3.2B | $634M – $3.8B | $2.9B (-11%) | after a round | 430 | flat | C | 3% |
| 1 Oct 2024 | $3.2B | $603M – $3.8B | $2.9B (-11%) | after a round | 430 | flat | C | 3% |
| 1 Nov 2024 | $1.4B | $564M – $3.8B | $932M (-33%) | after a round | 400 | down | C | 80% |
| 1 Dec 2024 | $1.4B | $537M – $3.8B | $905M (-33%) | after a round | 400 | down | C | 80% |
| 1 Jan 2025 | $1.3B | $510M – $3.8B | $878M (-33%) | after a round | 400 | down | D | 80% |
| 1 Feb 2025 | $1.3B | $485M – $3.8B | $852M (-34%) | after a round | 400 | down | D | 80% |
| 1 Mar 2025 | $1.2B | $463M – $3.8B | $829M (-34%) | after a round | 400 | down | D | 80% |
| 1 Apr 2025 | $1.2B | $440M – $3.8B | $805M (-34%) | after a round | 400 | down | D | 80% |
| 1 May 2025 | $1.3B | $419M – $3.8B | $865M (-32%) | after a round | 400 | flat | D | 73% |
| 1 Jun 2025 | $1.3B | $398M – $3.7B | $933M (-30%) | after a round | 400 | flat | D | 68% |
| 1 Jul 2025 | $1.4B | $379M – $3.7B | $1.0B (-27%) | after a round | 400 | flat | D | 62% |
| 1 Aug 2025 | $774M | $345M – $3.7B | $557M (-28%) | after a round | 329 | down | D | 97% |
| 1 Sep 2025 | $518M | $324M – $1.3B | $359M (-31%) | after a round | 313 | shrinking | C | 97% |
| 1 Oct 2025 | $497M | $309M – $1.3B | $359M (-28%) | after a round | 313 | shrinking | C | 97% |
| 1 Nov 2025 | $475M | $293M – $1.2B | $358M (-25%) | after a round | 309 | shrinking | C | 97% |
| 1 Dec 2025 | $455M | $279M – $1.2B | $358M (-21%) | after a round | 309 | shrinking | C | 97% |
| 1 Jan 2026 | $436M | $265M – $1.2B | $358M (-18%) | after a round | 309 | shrinking | C | 97% |
| 1 Feb 2026 | $417M | $252M – $1.1B | $358M (-14%) | after a round | 309 | shrinking | C | 97% |
| 1 Mar 2026 | $602M | $240M – $3.6B | $548M (-9%) | after a round | 309 | down | D | 97% |
| 1 Apr 2026 | $577M | $227M – $3.6B | $545M (-6%) | after a round | 300 | down | D | 97% |
| 1 May 2026 | $558M | $216M – $3.6B | $545M (-2%) | after a round | 300 | down | D | 97% |
| 1 Jun 2026 | $619M | $209M – $3.5B | $614M (-1%) | after a round | 302 | flat | D | 89% |
| 1 Jul 2026 | $693M | $209M – $3.5B | $685M (-1%) | after a round | 302 | flat | D | 82% |
| 1 Aug 2026 | $769M | $209M – $3.4B | $648M (-16%) | after a round | 302 | flat | D | 76% |
| 1 Sep 2026 | $844M | $209M – $3.4B | $720M (-15%) | after a round | 303 | flat | D | 70% |
| 1 Oct 2026 | $921M | $210M – $3.3B | $794M (-14%) | after a round | 306 | flat | D | 64% |
| 24 Oct 2026 | $716M | $151M – $3.3B | $633M (-12%) | after a round | 306 | flat | D | 59% |
Key facts about Pivot Bio
- Founded
- 2011
- Headquarters
- Berkeley, United States
- Employees
- about 306 -2% in a year
- Total raised
- $617M
- Funding rounds
- 5
- Last round
- Series D Jul 2021
Pivot Bio funding history
Pivot Bio has 5 funding rounds on record, from Jan 2014 to Jul 2021, $617M in total. The latest disclosed valuation is $2.00B post-money (Series D, Jul 2021).
Series D 19 Jul 2021
Led by DCVC, Temasek; with Generation Investment Management, G2 Venture Partners, Rockefeller Capital Management, Breakthrough Energy, Continental Grain Company, Prelude Ventures, Pavilion Capital, Bunge, Tekfen Ventures.
Sources: pivotbio.com, prnewswire.com, agfundernews.com and 3 more
$430M
$2.00B post-money
Series C 30 Apr 2020
Led by Breakthrough Energy, Temasek; with DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Bunge Ventures, Continental Grain Company, Tekfen Ventures, Pavilion Capital.
Sources: pivotbio.com, dcvc.com, globenewswire.com
$100M
Series B 2 Oct 2018
Led by Breakthrough Energy; with Temasek. Individuals: Alan Cohen.
Sources: pivotbio.com, prnewswire.com, globalaginvesting.com and 2 more
$70M
Series A 1 Jan 2016
Led by DCVC, Prelude Ventures; with Monsanto Growth Ventures, Bill & Melinda Gates Foundation, Genoa Ventures, OS Fund.
Sources: agfundernews.com
$16M
Seed 1 Jan 2014
Led by DCVC, Monsanto Growth Ventures.
$750K
Pivot Bio investors
18 investors have backed Pivot Bio; DCVC, Breakthrough Energy and Prelude Ventures and 2 more led at least one round.
- DCVC lead, 4 rounds
- Breakthrough Energy lead, 3 rounds
- Temasek lead, 3 rounds
- Monsanto Growth Ventures lead, 2 rounds
- Pavilion Capital 2 rounds
- Bill & Melinda Gates Foundation
- Bunge
- Bunge Ventures
- Codon Capital
- Generation Investment Management
- OS Fund
- Rockefeller Capital Management
What Pivot Bio does
Pivot Bio works in chemicals, with 13 recorded offerings and customers in agriculture.
Pivot Bio, Inc. is an American biotechnology company engaged in the development and commercialization of microbial nitrogen solutions for agriculture. The company focuses on creating microbial-based products that enhance crop nutrition by delivering nitrogen directly to plant roots, supporting sustainable and efficient crop production. Pivot Bio also conducts research and development in nitrogen fixation and crop nutrition, and distributes its products internationally through a network of independent sales representatives.
Description from Veridion's company data.
Products and services
- Microbial Nitrogen Product Manufacturing
- Microbial Nitrogen Technology Development
- Gene-Edited Microbe Research and Development
- Crop Nutrition Solutions Integration
- Sustainable Agriculture Solutions
- Farmer Collaboration Services
- Crop Productivity Enhancement Services
- Environmental Impact Reduction Services
- Agricultural Sustainability Consulting
- Global Crop Nutrition Product Distribution
- Agricultural Research and Reporting Services
- Agricultural Technology Innovation Services
- Agricultural Partnership Development Services
Markets
- Agriculture
Technology
- Gene-Edited Microbes for Nitrogen Fixation
Business model
- Business-to-Business
- Manufacturing
- Wholesale
Industry codes (NAICS)
- 325320 Pesticide and Other Agricultural Chemical Manufacturing 70% match
- 424910 Farm Supplies Merchant Wholesalers 30% match
Questions about Pivot Bio
What is Pivot Bio worth?
Valuation $716M (range $151M to $3.3B), as of 24 Oct 2026. The last disclosed valuation was $2.00B (Series D, Jul 2021).
Has Pivot Bio raised money?
Pivot Bio has 5 funding rounds on record, from Jan 2014 to Jul 2021, $617M in total. The latest disclosed valuation is $2.00B post-money (Series D, Jul 2021).
Who has invested in Pivot Bio?
DCVC, Breakthrough Energy, Prelude Ventures, Temasek, Monsanto Growth Ventures and Continental Grain Company, and 12 more. Lead investors include DCVC, Breakthrough Energy, Prelude Ventures and Temasek.
How many people work at Pivot Bio?
About 306, down 2% over the last year. Headcount rose from 130 in Jan 2021 to 480 in Oct 2023, then fell to 306 in Sep 2026.
What does Pivot Bio do?
Pivot Bio works in chemicals, with 13 recorded offerings and customers in agriculture. Its main offerings are microbial nitrogen product manufacturing, microbial nitrogen technology development and gene-edited microbe research and development.
When was Pivot Bio founded, and where is it based?
Pivot Bio was founded in 2011 and is based in Berkeley, United States. It has about 306 employees, down 2% over the last year.